Ingredient record · Blood pressure medicine (ARB)

Olmesartan: bans, restrictions and failed batches in India

Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026

2 entries containing Olmesartan are on India's banned-drugs list, and 1 is banned today. 8 batches of medicines containing Olmesartan failed a government lab test between January 2020 and December 2025, from 7 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.

1
Banned combinations in force
1
Other listed orders (stayed, restricted, quashed)
8
Batches failed a lab test
Dec 2025
Latest lab alert

On the banned-drugs list

Olmesartan on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.

Drug / combinationActionNotificationDateOrderStatus note
Olmesartan + Hydrochlorothiazide + ChlorthalidoneFixed-dose combination · cardiac Banned S.O. 4455(E) 7 September 2018 328 FDCs · Sep 2018 In force per CDSCO list as on 22.11.2021
Olmesartan + Hydrochlorothiazide + ChlorthalidoneFixed-dose combination · cardiac Quashed S.O. 787(E) 10 March 2016 344 FDCs · Mar 2016 Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban

Products that failed lab tests

Product names as printed by the testing labs, grouped. Open a product to see every batch number.

ProductBatchesMakersLatest
Olmesartan Medoxomil43Dec 2025
Olmesartan Medoxomil Olmeson11Dec 2025
Omitan11Apr 2023
Olmesartan Medoxomil Amlodipine11Mar 2022
Olmemark11Jan 2020

Most recent failed batches

Product Batch Manufacturer Reason declared NSQ Tested by Alert
Olmesartan Medoxomil Tablets IP 40 mg OLMESON-40 T-6585Mfg 2025-07 · Exp 2027-07 Jackson Laboratories Pvt.Ltd 22-24Punjab The sample received does not conform to I.P. 2022, I.P. addendum 2024 specification with respect to The test for Dissolution only.Dissolution CDTL-HyderabadCDSCO lab Dec 2025
Olmesartan Medoxomil Tablets IP 20mg GT250287Mfg 2025-02 · Exp 2027-01 Theon Pharmaceuticals LtdHimachal Pradesh Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution DTL Thiruvananthapuram,KeralaState lab Dec 2025
Olmesartan Medoxomil Tablets IP 40 mg LMT240387Mfg 2024-03 · Exp 2026-02 Life Max Cancer Laboratories Dissolution of Olmesartan MedoxomilDissolution RDTL GuwahatiCDSCO lab Aug 2024
Olmesartan Medoxomil Tablets IP 40 mg GT22183 1Mfg 2022-10 · Exp 2024-09 Theon Pharmaceuticals LtdHimachal Pradesh DissolutionDissolution RDTL ChandigarhCDSCO lab Jul 2023
Omitan ? 20 (Olmesartan Medoxomil Tablets I.P.) T-3567Mfg 2022-04 · Exp 2024-03 Jackson Laboratories Pvt. LtdPunjab Dissolution & AssayAssay CDL KolkataCDSCO lab Apr 2023
Olmesartan Medoxomil and Amlodipine Tablets (OLMISAVE AM-40 TABLETS) CT11211Mfg 2020-12 · Exp 2022-11 Cosmas Pharmacls LtdHimachal Pradesh AssayAssay RDTL ChandigarhState lab Mar 2022
Olmesartan Medoxomil Tablets IP Olmesartan Medoxomil I.P. 40mg 20S1GTA060Mfg 2020-06 · Exp 2022-05 Synokem Pharmaceuticals LtdUttarakhand DissolutionDissolution RDTL GuwahatiCDSCO lab Sep 2021
Olmemark-40 (Olmesartan Medoxomil Tablet IP 40 mg) TPT8689Mfg 2018-06 · Exp 2020-05 Trugen Pharmaceuticals Pvt. LtdUttarakhand DissolutionDissolution CDTL MumbaiCDSCO lab Jan 2020

Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.